Regeneron Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Regeneron Pharmaceuticals patents 453 in total
Status | Patent |
---|---|
Application | Utility: BISPECIFIC ANTI-MUC16 X ANTI-CD28 ANTIBODIES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: CE-WESTERN APPLICATIONS FOR ANTIBODY DEVELOPMENT Filling date: 13 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: NUCLEASE-MEDIATED REPEAT EXPANSION Filling date: 13 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: METHODS AND SYSTEMS FOR CHROMATOGRAPHY DATA ANALYSIS Filling date: 13 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: SYSTEM AND METHOD OF ANALYSIS OF A PROTEIN USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY Filling date: 13 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HUMANIZED SIGNAL-REGULATORY PROTEIN GENE Filling date: 13 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: HUMANIZED IL-15 ANIMALS Filling date: 13 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: Multimeric Protein Purity Determination Filling date: 13 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE Filling date: 13 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: HIGH CONCENTRATION PROTEIN FORMULATION Filling date: 13 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: ANTI-STAPHYLOCOCCUS ANTIBODIES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: Human Antibodies to GREM1 Filling date: 13 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: Non-Human Animals Comprising a Humanized ASGR1 Locus Filling date: 13 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS Filling date: 13 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: SERUM-FREE CELL CULTURE MEDIUM Filling date: 13 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN Filling date: 13 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: AUTO-INJECTOR WITH ANTI-ROLL FEATURES Filling date: 13 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: Tropism-Modified Recombinant Viral Particles and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells Filling date: 13 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: Tropism-Modified Recombinant Viral Vectors and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells Filling date: 13 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN Filling date: 13 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION Filling date: 13 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: PREDICTIVE AND PROGNOSTIC BIOMARKERS RELATED TO ANTI-ANGIOGENIC THERAPY OF METASTATIC COLORECTAL CANCER Filling date: 13 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: Method and System of Identifying and Quantifying A Protein Filling date: 13 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: Methods for Analysis of Viral Capsid Protein Composition Filling date: 13 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: Dosing Strategy that Mitigates Cytokine Release Syndrome for Therapeutic Antibodies Filling date: 13 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: ANTIGEN-BINDING PROTEINS THAT ANTAGONIZE LEPTIN RECEPTOR Filling date: 13 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE Filling date: 13 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: ANTI-NPR1 ANTIBODIES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: Methods and Antibody Compositions for Tumor Treatment Filling date: 13 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: STERILISATION METHOD Filling date: 13 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: Treatment of Fibrodysplasia Ossificans Progressiva Filling date: 13 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Receptors Filling date: 13 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: FIBRILLIN-1 MUTATIONS FOR MODELING NEONATAL PROGEROID SYNDROME WITH CONGENITAL LIPODYSTROPHY Filling date: 13 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: FAST PROTEIN SEQUENCING Filling date: 13 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING SUBJECTS HAVING RHEUMATOID ARTHRITIS Filling date: 13 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: STERILISATION METHOD Filling date: 13 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI Filling date: 13 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: Genetically Modified Non-Human Animals And Methods Of Use Thereof Filling date: 13 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: NEEDLE SHIELD GRIP DEVICES AND RELATED METHODS Filling date: 13 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: METHODS OF MAKING MULTISPECIFIC ANTIGEN-BINDING MOLECULES Filling date: 13 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: AUTO-INJECTOR Filling date: 13 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: METHODS FOR TREATING OR PREVENTING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF ANGPTL3 Filling date: 13 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: Methods and Systems for Pedigree Enrichment and Family-Based Analyses Within Pedigrees Filling date: 13 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: FUCOSYLATION-DEFICIENT CELLS Filling date: 13 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: Anti-IL-33 Antibodies and Uses Thereof Filling date: 13 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: Methods for Characterizing Protein Complexes Filling date: 13 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9 Filling date: 13 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: Methods for Treating Patients with Familial Hypercholesterolemia Filling date: 13 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO Filling date: 13 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: EFFICIENT SELECTIVITY OF RECOMBINANT PROTEINS Filling date: 13 Sep 2025 Issue date: 27 Feb 2020 |
Showing 300 to 350 of 453 patents.